Quick Takeaways
- RENAISSANCE TECHNOLOGIES LLC filed SCHEDULE 13G/A for UTAH MEDICAL PRODUCTS INC Common stock, $0.01 par value.
- Disclosed ownership: 6.7%.
- Date of event: 30 Sep 2024.
RENAISSANCE TECHNOLOGIES LLC - 30 Sep 2024 SCHEDULE 13G/A Report for UTAH MEDICAL PRODUCTS INC Common stock, $0.01 par value
- Filing Manager
- RENAISSANCE TECHNOLOGIES LLC
- Reporting Manager
- Renaissance Technologies LLC
- Shares outstanding
- 3,442,000 shares
- Disclosed Ownership
- 230,614 shares
- Ownership
- 6.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Nov 2024, 15:57:38 UTC
- Date of event
- 30 Sep 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"RENAISSANCE TECHNOLOGIES LLC disclosed 6.7% ownership in UTAH MEDICAL PRODUCTS INC Common stock, $0.01 par value on 30 Sep 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Nov 2024, 15:57.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | 6.7% | 230,614 | 230,614 | 0 | Brian Felczak | Chief Financial Officer | |
| Renaissance Technologies Holdings Corporation | 6.7% | 230,614 | 230,614 | 0 | Brian Felczak | Vice President |